A Study Comparing Ceftazidime-Avibactam Versus Meropenem in Hospitalized Adults With Nosocomial Pneumonia
Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the effects of Ceftazidime-Avibactam compared to
Meropenem for treating hospitalized adults with nosocomial pneumonia including
ventilator-associated pneumonia
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca Pfizer
Treatments:
Avibactam Avibactam, ceftazidime drug combination Ceftazidime Meropenem Thienamycins